Journal
ADVANCED DRUG DELIVERY REVIEWS
Volume 69, Issue -, Pages 254-269Publisher
ELSEVIER
DOI: 10.1016/j.addr.2013.12.004
Keywords
Cardiac cell therapy; Cardiac tissue engineering; Myocardial regeneration; Stem cells; Bioreactors; Three dimensional culture systems
Categories
Ask authors/readers for more resources
Ischemic Heart Disease (IHD) still represents the Number One Killer worldwide accounting for the death of numerous patients. However the capacity for self-regeneration of the adult heart is very limited and the loss of cardiomyocytes in the infarcted heart leads to continuous adverse cardiac-remodeling which often leads to heart-failure (HF). The concept of regenerative medicine comprising cell-based therapies, bio-engineering technologies and hybrid solutions has been proposed as a promising next-generation approach to address IHD and HF. Numerous strategies are under investigation evaluating the potential of regenerative medicine on the failing myocardium including classical cell-therapy concepts, three-dimensional culture techniques and tissue-engineering approaches. While most of these regenerative strategies have shown great potential in experimental studies, the translation into a clinical setting has either been limited or too rapid leaving many key questions unanswered. This review summarizes the current state-of-the-art, important challenges and future research directions as to regenerative approaches addressing IHD and resulting HF. (C) 2014 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available